Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-16-127348

Options or other derivatives

  • Director acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DESOUZA ERROL B · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-06-09 Grant or award : show line 1 in the form Stock Option (Right to Buy) +7,500 $1.88 2026-06-09 7,500 7,500 D
Loading xslF345X03/doc4.xml…